某年度美国外用止痛药市场分析报告(ppt 55页)

某年度美国外用止痛药市场分析报告内容提要：
Market Overview
Market Overview 一般情况
Major “Non-Natural Product” OTC Brands主要OTC品牌
Direct Natural Product Competitors: 主要天然产品竞争对手
Tiger Balm Case: Early Disappointment, Later Success 虎牌早期不满意后来较成功的案例
Capsasin Brands Case: Early Success, Later Disappointment 开普莎早期成功，后期不满意
O24 Case: Failure O24 的失败案例
ALCiS Case
Conclusion 结论
Market Overview
Market Overview
Major "Non-Natural Product" OTC Brands
Direct Natural Product Competitors:
Tiger Balm Case: Early Disappointment, Later Success
Capsasin Brands Case: Early Success, Later Disappointment
O24 Case: Failure
ALCiS Case
Conclusion
While the overall OTC and RX pain medication market combined is huge…镇痛药的处方药与OTC 整体市场很大
In 2003, the TOTAL U.S OTC and RX market for pain products was $12 billion： 03年120亿美元
By some measures, the US pain market alone is larger than the entire Chinese pharmaceutical market in 2003
…the market for topical OTC is only $500 M - $700 M 外用OTC药5-7亿美元
However, sales of OTC topical analgesics are estimated to be only $500 -$700 million
Prescription products, such as opioids and “NSAIDs” such as COX-2 inhibitors constitute most of the market. 口服的解热镇痛药如非甾抗炎药绝对为主
The market for COX-2’s alone (such as Vioxx and Celebrex) exceeds $5,000,000,000 (RMB 40,000,000,000). 仅环氧化酶2抑制剂药50亿美元

..............................